Akero Therapeutics Inc buy UBS Group AG
Start price
28.08.23
/
50%
€46.20
Target price
28.08.24
€76.75
Performance (%)
-48.68%
End price
29.08.24
€23.71
Summary
This prediction ended on 29.08.24 with a price of €23.71. Massive losses of -48.68% were the result for the BUY prediction by UBS_Group_AG. UBS_Group_AG has a follow-up prediction for Akero Therapeutics Inc where he still thinks Akero Therapeutics Inc is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | 0.278% | 0.278% | 70.552% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by UBS_Group_AG for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $83.00 price target on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€52.08
31.01.25
31.01.25
€105.08
31.01.26
31.01.26
-9.81%
08.12.25
08.12.25
Stopped prediction by UBS_Group_AG for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
05.03.24
05.03.24
€38.62
05.03.25
05.03.25
54.62%
06.03.25
06.03.25
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€14.00
12.10.23
12.10.23
€37.01
12.10.24
12.10.24
92.86%
13.10.24
13.10.24